Tag: Mauna
Mauna Kea Technologies launches patient recruitment for its clinical study – 06/01/2023 at 18:13
(AOF) – Mauna Kea Technologies announces today the initiation of patient recruitment as part of a clinical study aimed at evaluating the ability of its Cellvizio platform to help physicians…
Mauna Kea extends its financial visibility until the end of the 2nd quarter of 2024
By Alexandra Saintpierre Published on 05/31/2023 at 8:34 p.m. (Boursier.com) — Mauna Kea Technologies sets up an…
Mauna Kea Technologies announces the establishment of an equity financing line with Vester Finance limited to a maximum of 11.4% of the capital – 05/31/2023 at 6:30 p.m.
Paris and Boston, May 31, 2023 – 6:30 p.m. CEST – Mauna Kea Technologies (Euronext: MKEA), inventor of Cellvizio®, the multidisciplinary platform for confocal laser endomicroscopy by miniprobe and needle…
Mauna Kea Technologies soars after announcements
By Hector Chaunu Published on 04/21/2023 at 09:46 Photo credit © Mauna Kea (Boursier.com) — Mauna Kea Technologies…
Mauna Kea cuts its losses in 2022 – 04/06/2023 at 18:22
(AOF) – A global medical device company, Mauna Kea Technologies announces that its net loss amounted to 11.1 million euros as of December 31, 2022, down 2.26 million euros compared…
Mauna Kea: “a strategic pivot”?
Through Hector Chaunu Published on 01/27/2023 at 10:01 Mauna Kea remained stable at 0.454 euros on Friday after the announcement of sales for the…
Mauna Kea Technologies: fourth quarter results in line with expectations – 01/26/2023 at 6:30 pm
(AOF) – Mauna Kea Technologie, inventor of Cellvizio, the multidisciplinary platform for confocal laser endomicroscopy by probe and by needle, today announces its sales for the fourth quarter of 2022…
Mauna Kea: positive result for a study on robot-assisted bronchoscopy – 01/12/2023 at 18:06
(AOF) – Mauna Kea Technologies, today announces the results of a study demonstrating that robot-assisted bronchoscopic nCLE imaging for small peripheral lung lesions is feasible and safe and provides timely…
Mauna Kea Technologies posts a net loss in the first half – 11/16/2022 at 18:14
(AOF) – Global medical device company, Mauna Kea shows a net loss in the first half of 2022 to 6.2 million euros, reduced by 479,000 euros compared to the previous…
Mauna Kea: creation of a joint venture in China with Tasly – 2022-11-07 at 18:11
(CercleFinance.com) – Mauna Kea Technologies announces today that it has taken a new key step in its strategic partnership with Tasly Pharmaceutical Group with the creation of a joint venture…
Mauna Kea: creation of a joint venture in China with Tasly
(CercleFinance.com) – Mauna Kea Technologies announces today that it has taken a new key step in its strategic partnership with Tasly Pharmaceutical Group with the creation of a joint venture…
Mauna Kea Technologies and Tasly Pharmaceutical create their joint venture in China – 07/11/2022 at 18:17
(AOF) – Global medical device company that manufactures and markets Cellvizio, Mauna Kea Technologies and Tasly Pharmaceutical Group today announced that they have reached another key milestone in their strategic…